Protalex, Inc. Completes Analysis of Data from Phase 1b Dose Escalation Study of PRTX-100 in ...
15:58 EDT 29 Aug 2012 | LaMerie
New drug formulated from highly-purified form of staphylococcal protein A
Original Article: Protalex, Inc. Completes Analysis of Data from Phase 1b Dose Escalation Study of PRTX-100 in ...
More From BioPortfolio on "Protalex, Inc. Completes Analysis of Data from Phase 1b Dose Escalation Study of PRTX-100 in ..."
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
